Concord Medical Services Holdings Limited, incorporated on November 27, 2007, is engaged in the leasing of radiotherapy and diagnostic imaging equipment, the provision of management services to hospitals. The Company is also engaged in hospital operations. The Company's segments are network and premium cancer hospital. The Company operates a network of radiotherapy and diagnostic imaging centers in China. Its network consists of approximately 130 cooperative centers based in over 70 hospitals, spanning approximately 60 cities across 25 provinces and administrative regions in China. The Company's network includes approximately 60 radiotherapy centers and over 60 diagnostic imaging centers and approximately seven centers that provide other treatment and diagnostic services, such as electroencephalography for the diagnosis of epilepsy, thermotherapy to increase the efficacy of and for pain relief after radiotherapy and chemotherapy, high intensity focused ultrasound therapy for the treatment of cancer, stereotactic radiofrequency ablation for the treatment of Parkinson's Disease and refraction and tonometry for the diagnosis of ophthalmic conditions.
The Company's cooperative centers are equipped with a primary unit of medical equipment, such as a linear accelerator, head gamma knife system, body gamma knife system, positron emission tomography-computed tomography (PET-CT) scanner or magnetic resonance imaging (MRI) scanner. In addition to its cooperative centers, the Company is in the process of establishing specialty cancer hospitals that will focus on providing radiotherapy services, as well as diagnostic imaging services, chemotherapy and surgery. The Company owns approximately 30 linear accelerators and approximately 34 gamma knife systems, including over 22 head gamma knife systems and approximately 12 body gamma knife systems. It also owns approximately 20 PET-CT scanners and over 20 MRI scanners. The Company provides management services to radiotherapy and diagnostic imaging centers under service-only agreements. It also provides technical services to radiotherapy and diagnostic imaging centers under technical service agreements. The Company, through Concord Cancer Hospital, provides oncology as its main service, including medical oncology and surgical oncology, in Singapore.
The Company competes with China Renji Medical Group Ltd. and Jiancheng Investment Co.
4 Bridge St Office A-12
The company trades on NYSE exchange. The company headquarter is located in China. The company was established in the 2007.| Ticker | CCM |
| Long Name | Concord Medical Services Holdings Limited |
| Short Name | Concord Medical |